THREE Revíve:
The Joint Recovery Product
With a Longevity Secret

What Is THREE Revíve?

THREE Revíve is a renewal and recovery supplement produced by THREE International — the Lehi, Utah–based wellness company co-founded by Daniel Picou, Dr. Dan Gubler Ph.D. (Chief Scientific Officer), Kim Hui, and Christene Peterson. The formula comes in softgel form: 2 softgels daily or as needed, 60 per jar, representing a 30-day supply at the standard dose.

On its surface, Revíve is positioned as a joint support and post-exercise recovery product. That framing is accurate and supported by clinical ingredient evidence. But the THREE epigenetic gene expression study — conducted by Paul Davis Ph.D. and Catherine Davis Ph.D. at Trinity Bioactives Ltd — revealed something the marketing doesn't fully capture: Revíve is the broadest gene modulator in THREE's entire product line, active across all 7 gene categories tested, including a 164% upregulation of the SIRT1 longevity gene and a 384% upregulation of the ppara energy gene. These results were not expected from a recovery formula. They are the most compelling data point in the study.

I first used Revíve after attending THREE's launch convention in Salt Lake City as a Founding Member — before THREE had shipped products at scale. I've been using it consistently on appraisal site visit days, physical work days, and workout mornings for three years. Here is everything I found when I went to the actual clinical data.

Why Standard Curcumin Supplements Fail

Curcumin — the primary bioactive in turmeric — has an enormous volume of peer-reviewed research behind it. Anti-inflammatory mechanisms, joint health support, antioxidant activity, and even cognitive protection have all been studied. But a significant number of people who take standard turmeric or curcumin supplements report no measurable benefit. The ingredient is not the problem. The delivery is.

Curcumin has two structural challenges that most supplements fail to address:

1. Poor Aqueous Solubility

Curcumin is highly lipophilic — it dissolves in fat, not water. The human gut is primarily an aqueous environment. Standard curcumin capsules or powders largely remain undissolved in the intestinal fluid, meaning the molecule cannot efficiently approach the intestinal wall for absorption. The result: most of the dose is eliminated without ever crossing the cellular membrane.

2. Extensive First-Pass Metabolism

Even the fraction that does absorb faces rapid conjugation (sulfation and glucuronidation) in the intestinal wall and liver — a process known as first-pass metabolism. By the time curcumin reaches systemic circulation, plasma concentrations are negligible. Researchers have been studying this problem since the early 2000s, with multiple review papers confirming that unformulated curcumin has approximately 1% oral bioavailability in standard supplement form.

In THREE's Caco-2 cellular absorption assay — conducted by Dr. Brett Stephens Ph.D. of Wasatch Scientific alongside Dr. Dan Gubler — the curcumin control was set at 10% to reflect a standard organic molecule baseline. THREE Revíve, using quillaja saponin micelle delivery plus piperine and menthol adjuvants, achieved 30% cellular absorption. That is a 3× improvement over the baseline. It is the difference between a supplement that works and one that passes through.

How Quillaja Saponin Micelles Work

THREE's Cellular Absorption Technology (CAT) for Revíve is built on quillaja saponins — plant-derived glycoside molecules extracted from the soapbark tree (Quillaja saponaria). These molecules have an unusual structural property: they are amphiphilic, meaning they have both hydrophilic (water-attracting) and hydrophobic (fat-attracting) portions. In solution, they spontaneously self-assemble into spherical structures called micelles.

A micelle's outer surface is hydrophilic — compatible with the watery gut environment. Its inner core is hydrophobic — capable of capturing and retaining lipophilic compounds like curcumin, boswellic acids, and black cumin oil. The micelle effectively disguises fat-soluble actives in a water-soluble shell, allowing them to remain in solution, approach the intestinal wall, and cross the cellular membrane at significantly higher rates than unprotected molecules.

The Two Adjuvants: Piperine and Menthol

Beyond the quillaja micelle delivery system, Revíve includes two bioavailability-enhancing adjuvants:

Piperine (from black pepper extract) inhibits intestinal and hepatic metabolizing enzymes — including CYP3A4 and glucuronidation pathways — reducing first-pass metabolism of all co-ingested compounds. Studies on piperine's effect on curcumin absorption have shown significant plasma concentration increases. Piperine is well-established enough in the bioavailability literature that it appears in most high-quality curcumin formulations.

Menthol (from peppermint oil) functions as a permeation enhancer, modifying tight junction proteins in the intestinal epithelium to temporarily increase paracellular permeation — allowing larger molecules to pass between cells as well as through them. This works synergistically with the transcellular route facilitated by the quillaja micelles.

Key Ingredients: What's in Revíve and Why

Every ingredient in THREE Revíve has a defined functional role. Here is each one, with the mechanism it targets and the peer-reviewed context behind it:

The Epigenetic Study: 7 Genes, One Product

In 2023, THREE commissioned an epigenetic gene expression study conducted by Paul Davis Ph.D. and Catherine Davis Ph.D. of Trinity Bioactives Ltd, in collaboration with Dr. Dan Gubler Ph.D. The methodology used THLE-2 human liver cell lines exposed to THREE products at defined concentrations, with mRNA levels measured using qRT-PCR (quantitative real-time polymerase chain reaction) — the standard methodology for gene expression analysis.

Four THREE products were tested: Vitalité, Revíve, Éternel, and Collagène. Eight genes were assessed. THREE Revíve was the only product to show meaningful modulation across all 7 gene categories where it was tested. No other THREE product produced data across all categories simultaneously.

Here is the complete Revíve gene expression dataset from the 2023 epigenetic study, with concentration notes from the raw data:

↗ Read the Full Epigenetic Study (PDF)

Breaking Down Each Gene Result

PPARA (+384%) — Why This Matters for Energy: PPAR-alpha is a nuclear receptor that regulates fatty acid oxidation and ATP production at the cellular level. When upregulated, cells become more efficient at generating energy from fat. In the context of a recovery product, this is particularly relevant: post-exercise energy depletion and mitochondrial stress both respond positively to enhanced PPARA expression. Revíve's +384% was the highest PPARA result of any tested product, edging Éternel (+380%) for the top position.

BDNF (+430%) — The Brain Result From a Joint Product: Brain-derived neurotrophic factor governs neuroplasticity, memory consolidation, and the long-term health of neurons. The research literature on BDNF suppression and cognitive decline is extensive. A +430% upregulation from a product not marketed for cognitive health is an unexpected finding — likely attributable to the high polyphenol density from curcumin, boswellia, grape seed, and shiitake. The study authors noted this result was "surprising" and attributed it to the polyphenol content across the tested products.

SIRT1 (+164%) — The Longevity Gene: This is the result that separates Revíve from every comparable joint supplement on the market. Sirtuin-1 is one of the most intensively studied proteins in aging biology. SIRT1 regulates cellular stress response, promotes DNA damage repair, regulates circadian rhythms, and is involved in mitochondrial biogenesis. It is activated by caloric restriction and exercise — two of the most reliable life extension interventions known. The fact that Revíve produced SIRT1 activation in a validated cell study — from a formula built around curcumin, boswellia, and mushroom extract — is data no competitive product has produced. Because no other manufacturer has run this test on their joint supplements, this result stands alone.

GLP-1 (+293%) — The Unexpected Metabolic Angle: GLP-1 (glucagon-like peptide-1) is the hormone at the center of modern metabolic medicine — it signals satiety, reduces blood glucose, and slows gastric emptying. A joint recovery product producing 293% GLP-1 gene upregulation was not anticipated. The study authors were explicit about their surprise: "We were delighted when we saw that Vitalité and Revíve strongly activate the glp1 gene." This suggests that for someone focused on metabolic health alongside physical recovery, Revíve and Vitalité used together may address both targets simultaneously through different mechanisms.

NFKB (−200%) and IL-6 (−123%) — The Intended Anti-Inflammatory Effect: These two results confirm what Revíve's primary ingredients are designed to do. NF-κB is the master switch for inflammatory gene transcription; suppressing it reduces the downstream cascade of inflammatory signals. IL-6 is a primary pro-inflammatory cytokine elevated in chronic inflammation, post-exercise stress, and age-related inflammatory states. Revíve's suppression of both, while not as dramatic as Éternel's IL-6 result (−1,250%), is meaningful — particularly when combined with the energy and longevity gene upregulation happening simultaneously.

Who Should Consider THREE Revíve

Based on the clinical data, Revíve addresses several distinct profiles simultaneously. It is not a narrow single-purpose product:

The Disappointed Curcumin User

If you have taken turmeric capsules or standard curcumin supplements for joint support and noticed little to no benefit, the problem is almost certainly delivery, not expectation. Standard curcumin absorbs at approximately 10% — the same as the Caco-2 control in THREE's study. Most curcumin supplements have no meaningful delivery technology. Revíve's quillaja micelle system solves this at the source, delivering 30% absorption. This is likely the most commercially relevant story the product has to tell, and it applies to a very large population.

The Active Adult Over 45

Joint inflammation, post-exercise recovery time, and reduced physical resilience are reliable features of the aging process. Revíve's combination of curcumin, Boswellia, and grape seed extract addresses multiple inflammatory pathways simultaneously. The ergothioneine from shiitake mushroom is particularly relevant here — it accumulates in muscle tissue and mitigates exercise-induced oxidative stress, and its natural levels in the body decline with age.

The Longevity-Focused Professional

SIRT1 +164% is not something anyone marketing a joint supplement has previously generated in published cell data. For professionals in their 50s, 60s, and beyond who are thinking about healthspan — not just symptom relief — a recovery product that also activates a proven longevity pathway is a different kind of value proposition. The ppara +384% result compounds this: better cellular energy production combined with SIRT1 activation mirrors the gene expression profile associated with caloric restriction protocols.

The Metabolic Health Candidate

GLP-1 gene upregulation at 293% means Revíve may be worth considering alongside THREE's dedicated GLP THREE product for anyone focused on healthy weight and blood sugar. These two products work through entirely different mechanisms — GLP THREE activates the GLP-1 receptor via peptide binding; Revíve appears to upregulate the GLP-1 gene expression pathway itself. The combination has not been studied in human trials, but the mechanistic distinction is meaningful.

My Personal Assessment After 3 Years

I'm a professional appraiser by training, and I approach supplement claims the same way I approach a valuation dispute: show me the source documents. I spent two months independently reviewing THREE's clinical research before attending the launch convention and meeting the founders in person. The Caco-2 absorption study is methodologically valid — the assay is a pharmaceutical industry standard. The epigenetic study used human cell lines and qRT-PCR, which are legitimate tools.

What impressed me about Revíve specifically was not that it showed dramatic single-gene results — Éternel's IL-6 suppression at −1,250% is the dramatic headline. What impressed me was the breadth: Revíve was meaningful across all 7 gene categories simultaneously. That pattern — multiple, moderate, directionally correct gene modulations — is more consistent with what we'd expect from a polyphenol-dense formula than a single massive spike would be. It reads like honest data.

I disclose my compensation on every page. That disclosure exists because it's required by the FTC, and because I believe it's the right thing to do. I also know that disclosure makes readers appropriately skeptical, and I respect that. The way I address that skepticism is by linking to every primary source — the study PDFs, the fact sheets — so you can read the raw data yourself and form your own conclusion. The links are in this article. The data says what it says.

How to Take THREE Revíve

Recommended dose: 2 softgels daily or as needed. Each jar contains 60 softgels, making a 30-day supply at the standard 2-per-day protocol.

"As needed" means something here. Unlike a daily baseline supplement (Vitalité is Ed's recommendation for that), Revíve is formulated specifically for physical activity context. Taking it before or after significant physical exertion — field work, workouts, travel days with heavy walking — will put the curcumin, boswellia, and ergothioneine to work when the inflammatory stimulus is highest. I take 2 softgels on heavy field days and occasionally before long drives.

Consistency vs. acute dosing: The epigenetic gene expression data was generated under sustained exposure conditions (24-hour cell incubation). For the gene-level effects — particularly SIRT1 and PPARA — a daily consistent protocol is likely to produce more meaningful results than sporadic use. If your goal is joint recovery, "as needed" is appropriate. If your goal is the longevity and energy gene benefits, daily use is the better model.

Stacking with other THREE products: Revíve is designed as a complement, not a standalone protocol. The three-year stack I use personally: Vitalité (daily foundation), Revíve (active days), and Kynetik (energy on long content production days). For someone focused on metabolic health, adding GLP THREE addresses a different receptor pathway that Revíve's GLP-1 gene effect doesn't directly substitute for.

Revíve in the Context of the THREE Line

Where does Revíve sit relative to the other 7 THREE products? Here is an honest positioning assessment based on the clinical data:

Revíve vs. Éternel

Éternel achieved 95% cellular absorption (vs. Revíve's 30%) and the most dramatic single gene result in the study — IL-6 suppression at −1,250%. If inflammation is your primary concern, Éternel's data is stronger on the anti-inflammatory story. Revíve wins on breadth: it modulates 7 gene categories while Éternel modulates 4, and Revíve uniquely activates SIRT1. These are complementary, not competitive.

Revíve vs. Vitalité

Vitalité leads on BDNF (+840% vs. Revíve's +430%) and is THREE's foundational daily product. Vitalité is where I tell new THREE users to start. Revíve is where you go when you add physical activity, recovery needs, or longevity focus to the foundation. The GLP-1 overlap (Vitalité +348%, Revíve +293%) means both products support metabolic health through the gene expression pathway.

Revíve vs. Standard Curcumin/Turmeric Products

This is the most important comparison for most people evaluating Revíve. Standard curcumin supplements — regardless of dose — face the bioavailability ceiling at approximately 10%. Without a delivery technology that solves aqueous solubility and first-pass metabolism, the curcumin on the label is not the curcumin reaching your joints. Revíve's 30% absorption is 3× better than the standard baseline, and that difference is validated in a pharmaceutical-standard cell assay, not a marketing claim.

Common Questions About THREE Revíve